These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CD133: beyond a cancer stem cell biomarker. Barzegar Behrooz A; Syahir A; Ahmad S J Drug Target; 2019 Mar; 27(3):257-269. PubMed ID: 29911902 [TBL] [Abstract][Full Text] [Related]
5. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
7. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line. de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563 [TBL] [Abstract][Full Text] [Related]
8. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease. Pleskač P; Fargeas CA; Veselska R; Corbeil D; Skoda J Cell Mol Biol Lett; 2024 Mar; 29(1):41. PubMed ID: 38532366 [TBL] [Abstract][Full Text] [Related]
9. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Maeda K; Ding Q; Yoshimitsu M; Kuwahata T; Miyazaki Y; Tsukasa K; Hayashi T; Shinchi H; Natsugoe S; Takao S Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367674 [TBL] [Abstract][Full Text] [Related]
10. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties. Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729 [TBL] [Abstract][Full Text] [Related]
11. CD133: molecule of the moment. Mizrak D; Brittan M; Alison M J Pathol; 2008 Jan; 214(1):3-9. PubMed ID: 18067118 [TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of CD133 in cancer stem cells. Jang JW; Song Y; Kim SH; Kim J; Seo HR Life Sci; 2017 Sep; 184():25-29. PubMed ID: 28697984 [TBL] [Abstract][Full Text] [Related]
13. Prominin-1 (CD133): Molecular and Cellular Features Across Species. Corbeil D; Karbanová J; Fargeas CA; Jászai J Adv Exp Med Biol; 2013; 777():3-24. PubMed ID: 23161072 [TBL] [Abstract][Full Text] [Related]
17. The lipid rafts in cancer stem cell: a target to eradicate cancer. Zhang S; Zhu N; Li HF; Gu J; Zhang CJ; Liao DF; Qin L Stem Cell Res Ther; 2022 Aug; 13(1):432. PubMed ID: 36042526 [TBL] [Abstract][Full Text] [Related]
18. Isolation of Lipid Rafts from Human Neutrophils by Density Gradient Centrifugation. Fortin C; Fülöp T Methods Mol Biol; 2015; 1343():1-7. PubMed ID: 26420704 [TBL] [Abstract][Full Text] [Related]
19. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma. Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699 [TBL] [Abstract][Full Text] [Related]
20. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]